Nirmala Bhoo Pathy: Critical report on strengthening primary healthcare for cancer control in Southeast Asia was a privilege
Nirmala Bhoo Pathy made the following post on LinkedIn:
“Contributing to this critical report on strengthening primary healthcare for cancer control in Southeast Asia was a privilege.
A tapestry woven from expertise, policy, and lived experience – bound by a commitment to equitable access – laid the groundwork for this impactful work.
Kenneth Hartigan-Go, Stephen Jan, Kara Magsanoc-Alikpala, Cecilia B. Padilla and Carolyn Taylor.
Key points:
- Strengthening Southeast Asia’s primary healthcare is crucial for equitable cancer control, as it often serves as the only accessible option, especially in rural areas.
- Tackling access barriers requires a multi-pronged approach, including bolstering healthcare workforce training, leveraging digital tools, and empowering communities.
- Training healthcare workers in task shifting and utilizing teleconsultation, telementoring, and translated health apps are essential for rural areas.
- The pandemic’s lessons, like remote training’s potential and increased political will, should be harnessed for lasting cancer control efforts.Thanks to Alexandra Zenoff and Asia Society for bringing us together, this piece is amazing!”
Additional information.
Source: Nirmala Bhoo Pathy/LinkedIn
Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician at Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014.
Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).
She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023